Introduction: Calcification on native kidney biopsy specimens is often noted by pathologists, but the consequence is unknown. Methods: We searched the pathology reports in the Biopsy Biobank Cohort of Indiana for native biopsy specimens with calcification. Results: Of the 4,364 specimens, 416 (9.8%) had calcification. We compared clinical and histopathology findings in those with calcification (n = 429) compared to those without calcification (n = 3,936). Patients with calcification were older, had more comorbidities, lower estimated glomerular filtration rates (eGFR), were more likely to have hyaline arteriosclerosis, interstitial fibrosis/tubular atrophy, and a primary pathologic diagnosis of acute tubular injury or acute tubular necrosis when compared to patients without calcification. Patients with calcium oxalate deposition alone, compared to calcium phosphate or mixed calcifications, had fewer comorbidities but were more likely to have a history of gastric bypass surgery or malabsorption and take vitamin D. In patients with two or more years of follow-up, multivariate analyses showed the presence of calcification (HR 0.59, 0.38–0.92, p = 0.02) and higher eGFR (HR 0.76, 0.73–0.79, p < 0.001), was associated with decreased likelihood of progressing to end-stage renal disease. The presence of calcification was also associated with a reduced slope/decline in eGFR compared to known biopsy and clinical risk factors for decline in kidney function. We hypothesized this was due to more recoverable acute kidney injury (AKI) and found more severe acute kidney injury network stage in patients with kidney calcification but also greater improvement over time. Discussion/Conclusion: In summary, we demonstrated that calcification on kidney biopsy specimens was associated with a better prognosis than those without calcification due to the association with recoverable AKI.

1.
Chen
NX
,
Moe
SM
.
Pathophysiology of vascular calcification
.
Curr Osteoporos Rep
.
2015 Dec
;
13
(
6
):
372
80
. .
2.
Chen
NX
,
O’Neill
KD
,
Moe
SM
.
Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways
.
Kidney Int
.
2018 Feb
;
93
(
2
):
343
54
. .
3.
Ciancaglini
P
,
Simao
AM
,
Camolezi
FL
,
Millan
JL
,
Pizauro
JM
.
Contribution of matrix vesicles and alkaline phosphatase to ectopic bone formation
.
Braz J Med Biol Res
.
2006 May
;
39
(
5
):
603
10
. .
4.
Hasegawa
T
.
Ultrastructure and biological function of matrix vesicles in bone mineralization
.
Histochem Cell Biol
.
2018 Apr
;
149
(
4
):
289
304
. .
5.
Lorenz
EC
,
Michet
CJ
,
Milliner
DS
,
Lieske
JC
.
Update on oxalate crystal disease
.
Curr Rheumatol Rep
.
2013 Jul
;
15
(
7
):
340
. .
6.
Geraghty
R
,
Wood
K
,
Sayer
JA
.
Calcium oxalate crystal deposition in the kidney: identification, causes and consequences
.
Urolithiasis
.
2020 Oct
;
48
(
5
):
377
84
. .
7.
Eadon
MT
,
Schwantes-An
TH
,
Phillips
CL
,
Roberts
AR
,
Greene
CV
,
Hallab
A
,
Kidney histopathology and prediction of kidney failure: a retrospective Cohort study
.
Am J Kidney Dis
.
2020 Sep
;
76
(
3
):
350
60
. .
8.
Moe
SM
,
Pampalone
AJ
,
Ofner
S
,
Rosenman
M
,
Teal
E
,
Hui
SL
.
Association of hepatitis C virus infection with prevalence and development of kidney disease
.
Am J Kidney Dis
.
2008 Jun
;
51
(
6
):
885
92
. .
9.
Rosenman
M
,
He
J
,
Martin
J
,
Nutakki
K
,
Eckert
G
,
Lane
K
,
Database queries for hospitalizations for acute congestive heart failure: flexible methods and validation based on set theory
.
J Am Med Inform Assoc
.
2014 Mar–Apr
;
21
(
2
):
345
52
. .
10.
Zhu
VJ
,
Tu
W
,
Rosenman
MB
,
Overhage
JM
.
Nonadherence to oral antihyperglycemic agents: subsequent hospitalization and mortality among patients with type 2 diabetes in clinical practice
.
Stud Health Technol Inform
.
2015
;
216
:
60
3
.
11.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
 3rd
,
Feldman
HI
,
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009 May 5
;
150
(
9
):
604
. .
12.
Mehta
RL
,
Kellum
JA
,
Shah
SV
,
Molitoris
BA
,
Ronco
C
,
Warnock
DG
,
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
.
Crit Care
.
2007
;
11
(
2
):
R31
. .
13.
Evan
AP
,
Lingeman
JE
,
Worcester
EM
,
Bledsoe
SB
,
Sommer
AJ
,
Williams
JC
 Jr
,
Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease
.
Kidney Int
.
2010 Aug
;
78
(
3
):
310
7
. .
14.
Evan
AP
,
Coe
FL
,
Gillen
D
,
Lingeman
JE
,
Bledsoe
S
,
Worcester
EM
.
Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones
.
Anat Rec
.
2008 Mar
;
291
(
3
):
325
34
. .
15.
Torres
JA
,
Rezaei
M
,
Broderick
C
,
Lin
L
,
Wang
X
,
Hoppe
B
,
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
.
J Clin Invest
.
2019 Jul 30
;
129
(
10
):
4506
22
. .
16.
Truong
LD
,
Yakupoglu
U
,
Feig
D
,
Hicks
J
,
Cartwight
J
,
Sheikh-Hamad
D
,
Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications
.
Am J Transpl
.
2004 Aug
;
4
(
8
):
1338
44
. .
17.
Bagnasco
SM
,
Mohammed
BS
,
Mani
H
,
Gandolfo
MT
,
Haas
M
,
Racusen
LC
,
Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function
.
Nephrol Dial Transpl
.
2008
;
24
(
4
):
1319
25
. .
18.
Palsson
R
,
Chandraker
AK
,
Curhan
GC
,
Rennke
HG
,
McMahon
GM
,
Waikar
SS
.
The association of calcium oxalate deposition in kidney allografts with graft and patient survival
.
Nephrol Dial Transpl
.
2020 May 1
;
35
(
5
):
888
94
. .
19.
Pinheiro
HS
,
Camara
NOS
,
Osaki
KS
,
De Moura
LAR
,
Pacheco-Silva
A
.
Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival
.
Am J Transpl
.
2005 Feb
;
5
(
2
):
323
9
. .
20.
Snijders
MLH
,
Hesselink
DA
,
Clahsen-van Groningen
MC
,
Roodnat
JI
.
Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction
.
PLoS One
.
2019
;
14
(
4
):
e0214940
. .
21.
Elgstoen
KBP
,
Johnsen
LF
,
Woldseth
B
,
Morkrid
L
,
Hartmann
A
.
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria
.
Nephrol Dial Transpl
.
2010 Jul
;
25
(
7
):
2341
5
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.